NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow

Launched by THE CLEVELAND CLINIC · Apr 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at different pain relief options for people who have elbow pain, specifically after a procedure called percutaneous needle tenotomy, which is done to treat a condition called tendinosis in the elbow. The study will compare three types of oral medications—acetaminophen, diclofenac, and tramadol—to see which one helps reduce the need for narcotic painkillers. The goal is to find a way to manage pain effectively while minimizing the use of stronger, addictive medications.

To participate in this study, you need to be between 18 and 65 years old and have a specific type of elbow pain diagnosed through an ultrasound or MRI. You must also be able to take oral medications and commit to following the study procedures for about two weeks. If you have had prior elbow surgery, certain medical conditions, or are taking other investigational drugs, you may not be eligible. Participants will be monitored for their pain levels and medication use, and everyone involved will be kept in the dark about which medication they are receiving to ensure fair results.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Provision of signed and dated informed consent form
• • Stated willingness to comply with all study procedures and availability for the duration of the study
• • Male or female, aged 18-65 years
• • Percutaneous Needle Tenotomy of Lateral Elbow Procedure
• • Ability to take oral medication and willingness to participate in a 2-week follow-up pill counts
• • Musculoskeletal ultrasound or MRI with diagnosis of tendinosis of the common extensor tendon of the elbow
• Exclusion Criteria:
• • • Any full thickness common extensor tendon tear of the elbow
• • Prior history of elbow surgery
• • Symptomatic cervical radiculopathy
• • Concurrent symptoms of the medial elbow
• • Treatment with another investigational drug or other intervention concurrently or previously that would interfere with postoperative pain control
• • Psychiatric illness that impedes evaluation of pain and/or narcotics use
• • No history of inflammatory arthritis, diabetes, chronic regional pain syndrome, connective tissue disease, fibromyalgia or autoimmune disease
• • No contraindications to NSAIDs or Opioids